Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Pharm Res ; 28(7): 1561-76, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21347567

ABSTRACT

PURPOSE: To quantify and compare the time-course and potency of the analgesic and antipyretic effects of naproxen in conjunction with the inhibition of PGE(2) and TXB(2). METHODS: Analgesia was investigated in a rat model with carrageenan-induced arthritis using a gait analysis method. Antipyretics were studied in a yeast-induced fever model using telemetrically recorded body temperature. Inhibition of TXB(2) and PGE(2) synthesis was determined ex vivo. Pharmacokinetic profiles were obtained in satellite animals. Population PKPD modeling was used to analyze the data. RESULTS: The IC(50) values (95% CI) of naproxen for analgesia (27 (0-130) µM), antipyretics (40 (30-65) µM) and inhibition of PGE(2) (13 (6-45) µM) were in similar range, whereas inhibition of TXB(2) (5 (4-8) µM) was observed at lower concentrations. Variability in the behavioral measurement of analgesia was larger than for the other endpoints. The inhibition of fever by naproxen was followed by an increased rebound body temperature. CONCLUSION: Due to better sensitivity and similar drug-induced inhibition, the biomarker PGE(2) and the antipyretic effect would be suitable alternative endpoints to the analgesic effects for characterization and comparisons of potency and time-courses of drug candidates affecting the COX-2 pathway and to support human dose projections.


Subject(s)
Dinoprostone/metabolism , Gene Expression Regulation/drug effects , Models, Chemical , Naproxen/pharmacology , Naproxen/pharmacokinetics , T-Box Domain Proteins/metabolism , Animals , Antipyretics/pharmacokinetics , Antipyretics/pharmacology , Arthritis/drug therapy , Arthritis/metabolism , Disease Models, Animal , Fever/drug therapy , Fever/metabolism , Inhibitory Concentration 50 , Male , Oxytocics/antagonists & inhibitors , Oxytocics/pharmacokinetics , Oxytocics/pharmacology , Pain/drug therapy , Pain/metabolism , Rats , Rats, Sprague-Dawley , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...